HCW Biologics (HCWB) EBIT Margin (2022 - 2026)
HCW Biologics' EBIT Margin was -2335.57% in Q2 2026, up 50551.10 percentage points from -52886.67% a year earlier.
Powered by 
Analysis
HCW Biologics (HCWB) EBIT Margin (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, HCW Biologics' EBIT Margin was -7786.50% through Jun 30, 2026, down 6314.20 percentage points year-over-year; for FY2025, it came in at -24270.74%, down 23123.14 percentage points from FY2024.
- EBIT Margin has now declined for three consecutive years, with a five-year change of -24128.67 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was -1147.60% in FY2024 (-242.64 pp), -904.96% in FY2023 (-680.65 pp) and -224.32% in FY2022.
- The Q2 2026 figure marks the highest quarterly EBIT Margin since Q4 2024.
- Compared with a year earlier, EBIT Margin was higher in two of the last seven quarters, with an average year-over-year change of -10606.00 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q2 2026 (a gain of 50551.10 percentage points); the worst was Q2 2025 (a drop of 50440.86 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | HCW Biologics | 2.27 Mn | -3.96 Mn | -93,887.00 | -2,335.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,335.57% |
| Dec 31, 2025 | -16,519.15% |
| Sep 30, 2025 | -21,095.26% |
| Jun 30, 2025 | -52,886.67% |
| Mar 31, 2025 | -38,811.49% |
| Dec 31, 2024 | -797.23% |
| Sep 30, 2024 | -864.06% |
| Jun 30, 2024 | -2,445.81% |
| Mar 31, 2024 | -665.09% |
| Dec 31, 2023 | -813.31% |
| Sep 30, 2023 | -595.23% |
| Jun 30, 2023 | -724.22% |
| Mar 31, 2023 | -12,798.92% |
| Dec 31, 2022 | -422.45% |
| Sep 30, 2022 | -222.20% |
| Jun 30, 2022 | -773.36% |
| Mar 31, 2022 | -60.33% |
API Access
HCW Biologics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=HCWB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "HCWB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=HCWB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();